Get access to our best features
Get access to our best features
Published

The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine

  • The U.S. Government will provide Moderna with $176 million to speed up the development of a pandemic influenza vaccine.
  • Moderna's early-stage bird flu vaccine, using mRNA technology like COVID-19 vaccines, receives further funding for continued development and possible late-stage trials.
  • The project can pivot to target different influenza strains as needed, ensuring readiness for large-scale production during public health emergencies.
Insights by Ground AI
Does this summary seem wrong?

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
49% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

You have read 0 out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.